Algert Global LLC Maravai Lifesciences Holdings, Inc. Transaction History

Algert Global LLC

$4.25 Billion
Q4 2024

A detailed history of Algert Global LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Algert Global LLC holds 147,459 shares of MRVI stock, worth $606,056. This represents 0.02% of its overall portfolio holdings.

Number of Shares

147,459

Previous 101,718 44.97%

Holding current value

$606,056

Previous $845,000 4.85%

% of portfolio

0.02%

Previous 0.02%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.42 - $8.5 $202,175 - $388,798	45,741 Added 44.97%	147,459 $804,000
Q3 2024 Nov 12, 2024	SELL	$6.84 - $9.73 $336,254 - $478,326	-49,160 Reduced 32.58%	101,718 $845,000
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $1.04 Million - $1.71 Million	150,878 New	150,878 $1.08 Million
Q1 2023 May 12, 2023	BUY	$12.99 - $16.48 $38,957 - $49,423	2,999 Added 6.8%	47,113 $660,000
Q4 2022 Feb 13, 2023	SELL	$12.5 - $24.78 $350,500 - $694,831	-28,040 Reduced 38.86%	44,114 $631,000
Q3 2022 Nov 15, 2022	BUY	$20.6 - $30.37 $178,210 - $262,730	8,651 Added 13.62%	72,154 $1.84 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $90,627 - $130,392	3,479 Added 5.8%	63,503 $1.8 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $745,516 - $1.25 Million	30,479 Added 103.16%	60,024 $2.12 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $740,425 - $971,860	21,155 Added 252.15%	29,545 $1.24 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $308,752 - $508,601	8,390 New	8,390 $412,000

Others Institutions Holding MRVI

# of Institutions

203

Shares Held

138M

Call Options Held

271K

Put Options Held

37.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $541M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Maravai Lifesciences Holdings, Inc. Transaction History